ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023
[
Open access · bronzeAbstract read
In one paragraph
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 17 citations in OpenAlex.
- Associations of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026Article
- Dynamic [Molecular neurodegeneration · 2026Article
- TogoPhosTAC as a delivery-ready platform for targeted protein dephosphorylation.Nature communications · 2026Article
- Emerging directions in tauopathy research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Review
- Longitudinal monitoring of tau aggregation in progressive supranuclear palsy with [Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- From clinical phenotypes to molecular stratification: early differential diagnosis of four-repeat tauopathies.Frontiers in aging neuroscience · 2026Review
- A Biomarker-Based Classification of Corticobasal Syndrome.Movement disorders : official journal of the Movement Disorder Society · 2026Article
- Developing a novel reference region for [European journal of nuclear medicine and molecular imaging · 2025Article
- Development of Novel PET Tracers for Imaging Non-AD Tauopathies.ACS medicinal chemistry letters · 2025Article
- Co-occurrence of multiple pathologies in a case of frontotemporal dementia with TBK1 mutation: first in vivo detection of alpha-synuclein and tau co-pathology.Acta neuropathologica communications · 2025Article
- Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1Journal of medicinal chemistry · 2025Article
- Strategies of positron emission tomography (PET) tracer development for imaging of tau and α-synuclein in neurodegenerative disorders.RSC medicinal chemistry · 2025Review
- Article
- Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies.Acta neuropathologica · 2024Article
- [18F]PI-2620 Tau PET signal across the aging and Alzheimer's disease clinical spectrum.Imaging neuroscience (Cambridge, Mass.) · 2024Article
- Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan.Brain communications · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 11 institutions in 3 countries.
Ganna BlazhenetsMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
David N Soleimani-MeigooniMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Wesley ThomasLawrence Berkeley National Laboratory, Berkeley, California.
Nidhi MundadaMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Stephanie VentoMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Lawren VandeVredeMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Hilary W HeuerMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Peter LjubenkovMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Julio C RojasMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Miranda K ChenMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Alinda N AmuiriMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Zachary MillerMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Maria L Gorno-TempiniMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Bruce L MillerMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Howie J RosenMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Irene LitvanUniversity of California, San Diego, San Diego, California.
Murray GrossmanPenn FTD Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Brad BoeveMayo Clinic, Rochester, Minnesota.
Alexander PantelyatJohns Hopkins University School of Medicine, Baltimore, Maryland.
Maria Carmela TartagliaUniversity of Toronto, Toronto, Ontario, Canada.
David J IrwinPenn FTD Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Brad C DickersonMassachussets General Hospital, Boston, Massachusetts; and.
Suzanne L BakerLawrence Berkeley National Laboratory, Berkeley, California.
Adam L BoxerMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Gil D RabinoviciMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
Renaud La JoieMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California; renaud.lajoie@ucsf.edu.
University Memory and Aging Center · USUniversity of California, San Francisco · USLawrence Berkeley National Laboratory · USPenn Center for AIDS Research · USJohns Hopkins University · USLudwig-Maximilians-Universität München · DEMassachusetts General Hospital · USMayo Clinic · USUniversity Medical Center Freiburg · DEUniversity of California, San Diego · USUniversity of Toronto · CA
Funding
Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI KEJAL KANTARCI · 2019 to 2026
$120.9MTDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2MThe Four Repeat Tauopathy Neuroimaging InitiativeR01AG038791 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2010 to 2020
$18.1MDementia with Lewy Bodies Consortium - Supplement for ASL sequenceU01NS100610 · NINDS · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI DOUGLAS R GALASKO, JAMES Bruce LEVERENZ · 2016 to 2026
$15.6MClinical Coordination Center for STEADY-PD3U01NS080818 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SIMUNI, TANYA · 2014 to 2018
$13.0MProgressive Aphasia Cognition Anatomy and ProgressionR01NS050915 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI · 2004 to 2026
$11.0MPrimary Progressive Aphasia: Cognition, Anatomy and ProgressionRF1NS050915 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORNO TEMPINI, MARIA LUISA · 2022 to 2022
$4.7MBIOMARKER DISCOVERY AND VALIDATION IN PSPU01NS102035 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PANTELYAT, ALEXANDER Y. · 2018 to 2022
$4.5MPhase IIB: A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration SyndromesR44AG080861 · NIA · BIOSENSICS, LLC · PI ADAM L. BOXER, Irene Litvan · 2022 to 2026
$3.5MTraining in Research to Assure Neuroscience Scholars Cultivate Expertise in Notable Disparities Science (TRANSCENDS)R25NS098999 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BRUCE OVBIAGELE · 2017 to 2026
$2.5MTraining program in the neurology of language and neurodegenerative aphasiasK24DC015544 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORNO TEMPINI, MARIA LUISA · 2016 to 2025
$1.9MMultimodal Imaging in Frontotemporal DegenerationK24AG045333 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2013 to 2023
$1.9MNIA NIH HHS K23 AG059888NIA NIH HHS K23 AG059891NIA NIH HHS K23 AG073514NIA NIH HHS K23 AG076960NIA NIH HHS K24 AG045333NIA NIH HHS L30 AG069301NIA NIH HHS P01 AG019724NIA NIH HHS R01 AG038791NIA NIH HHS R44 AG080861NIA NIH HHS U19 AG063911NIDCD NIH HHS K24 DC015544NINDS NIH HHS R01 NS050915NINDS NIH HHS R21 NS114764NINDS NIH HHS R25 NS098999NINDS NIH HHS RF1 NS050915NINDS NIH HHS U01 NS080818NINDS NIH HHS U01 NS100610NINDS NIH HHS U01 NS102035
Abstract
Tau PET has enabled the visualization of paired helical filaments of 3 or 4 C-terminal repeat tau in Alzheimer disease (AD), but its ability to detect aggregated tau in frontotemporal lobar degeneration (FTLD) spectrum disorders is uncertain. We investigated 2-(2-([
Indexed as
Alzheimer DiseaseAphasia, Primary ProgressiveCorticobasal DegenerationFrontotemporal DementiaFrontotemporal Lobar DegenerationSupranuclear Palsy, ProgressiveAmyloid beta-PeptidesHumansPositron-Emission TomographyPyridinestau ProteinsAmyloid beta-PeptidesPI-2620Pyridinestau ProteinsAlzheimer diseaseFTLDPI2620tau PET
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.